What's the outlook for ASX healthcare shares in Q2?

Here are some of the numbers looking ahead.

| More on:
A doctor appears shocked as he looks through binoculars on a blue background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX healthcare shares have been underwhelming this year
  • Projections for the industry are a little more optimistic, with some of the larger players looking to secure gains
  • We've crunched the numbers to see what's on the horizon for the industry

ASX healthcare shares have been a mixed bag in 2022. The industry was flourishing during the later part of the last calendar year but took a turn as early as November.

The downside continued along with the broader sell-off in equities. However, unlike most other industries, it has failed to reclaim a good portion of the losses.

The S&P/ASX 200 Health Care Index (ASX: XHJ) is down more than 10% this year to date and is sitting around the same over the past 12 months.

What are the projections?

Healthcare is seen as a 'defensive' industry that is largely insensitive to the business cycle. With this in mind, the current and forward-looking economic climate are of interest to those looking at ASX healthcare shares.

The industry trades on a price-to-earnings (P/E) ratio of 30.09 times at the time of writing, and has delivered a trailing dividend yield of 1.62%.

Some of the largest players, such as CSL Limited (ASX: CSL), Resmed Inc (ASX: RMD), and Sonic Healthcare Limited (ASX: SHL), reside within this portion of the market.

Each of these dominant names has numerous bullish price targets that point to strength in the industry across a diverse array of services.

CSL is rated a buy from 13 out of 16 brokers covering the share, with a $320 consensus price target (all data sourced from Refinitiv Eikon). The CSL share price closed on Friday at $280.43.

Meanwhile, Resmed is also tipped as a buy from nine out of 14 analysts, with a consensus valuation of $36.10. Resmed shares ended Friday's session trading for $34.14 apiece.

Sonic is rated a buy from six out of the 15 analysts covering it, with a $35.86 price target assigned. The Sonic share price is $30.55 as of Friday's close.

Noteworthy is that each consensus price target is priced above the current market value of each share.

In addition, some of the largest ASX healthcare shares are posted in the table below, with their respective fundamentals. All figures are in millions of dollars (except earnings per share and percentage).

NameRevenue [$million]EBITDANet IncomeEPSFree Cash FlowROE (%)
S&P/ASX 200 Health Care Index (ASX: XHJ)1,992.3514.4281.6 $     0.8898.816.3
CSL Limited (ASX: CSL)15,304.95534.73267.2 $     6.97740.219.6
Resmed Inc (ASX: RMD)5,185.01683.51129.5 $     7.68779.125.0
Sonic Healthcare Limited (ASX: SHL)9,340.22835.81460.6 $     3.021356.921.4
Ramsay Health Care Limited (ASX: RHC)13,210.21334.1274.0 $     1.16229.36.9
Cochlear Limited (ASX: COH)1,648.3471.2289.1 $     4.4095.117.1
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)15,58.9557.7349.4 $     0.6072.523.6
Pro Medicus Limited (ASX: PME)94.169.344.4 $     0.4223.948.5
Ansell Limited (ASX: ANN)2,828.7470.9230.0 $     1.79102.610.3
Healius Ltd (ASX: HLS)2,336.2766.9307.9 $     0.52380.915.6
Telix Pharmaceuticals Ltd (ASX: TLS)7.6-71.8-80.5 $   (0.29)-76.7-198.4
Imugene Limited (ASX: IMU)0.0-35.3-37.9 $   (0.01)-35.7-37.2
Nanosonics Ltd (ASX: NAN)120.37.63.7 $     0.012.52.7

With that, we can observe some names from the above list with projected earnings over the next two years in the table below as well.

 EPS   
NamePrevThis yearFY24FY25
S&P/ASX 200 Health Care (GIC) $   1.32 $   0.86 $   1.18 $   1.56
Resmed Inc $   4.32 $   7.68 $   8.47 $   9.46
CSL Ltd $   6.94 $   6.97 $   8.56 $ 10.40
Cochlear Ltd $   4.97 $   4.40 $   5.31 $   6.65
Sonic Healthcare Ltd $   2.73 $   3.02 $   1.72 $   1.56
Ansell Ltd $   2.53 $   1.79 $   2.23 $   2.09
Ramsay Health Care Ltd $   1.80 $   1.13 $   2.98 $   3.13
Fisher & Paykel Healthcare Corporation Ltd $   0.83 $   0.60 $   0.64 $   0.74
Healius Ltd $   0.11 $   0.50 $   0.21 $   0.22
Pro Medicus Ltd $   0.29 $   0.42 $   0.54 $   0.65
Nanosonics Ltd $   0.03 $   0.01 $   0.09 — 
Imugene Ltd $ (0.00) $ (0.01) $ (0.01) $ (0.01)
Telix Pharmaceuticals Ltd $ (0.17) $ (0.29) $ (0.30) $ (0.03)

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A worried woman looks at her phone and laptop, seeking ways to tighten her belt against inflation.
Healthcare Shares

This ASX share potentially 'has no value from here', says broker

This is every investor's worst nightmare.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Healthcare Shares

Should I buy Fisher & Paykel or ResMed shares?

Let's see which of these two names could be best buys.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

This company has entered a trading halt, is it about to announce FDA approval?

This regenerative medicine company is up more than 260% in the last year.

Read more »

a young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Healthcare Shares

How are Cochlear shares impacted by Trump's tariffs?

Will the company escape from the tariffs? Let's find out.

Read more »

A man with a wide, eager smile on his face holds up three fingers.
Healthcare Shares

3 reasons to buy this surging ASX All Ords healthcare share today

A top expert forecasts more outperformance from this rocketing ASX healthcare stock.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

Down 11% in 2025, are CSL shares a good buy right now?

Are CSL shares likely to go up from here?

Read more »

Three healthcare workers look and point at at medical image
Healthcare Shares

Pro Medicus to buyback 10.4 million shares. What does this mean?

Is this a sign to buy?

Read more »

A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares
Healthcare Shares

Why I think this ASX small-cap stock is a bargain at 40 cents

Here’s why this business has a compelling outlook...

Read more »